LCS
DRTS icon

Levin Capital Strategies’s Alpha Tau Medical DRTS Stock Holding History

Levin Capital Strategies’s Portfolio DRTS Stock Details DRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.62M Buy
128,594
+22,171
+21% +$201K 0.11% 114
2026
Q1 		$752K Sell
106,423
-75,808
-42% -$535K 0.06% 129
2025
Q4 		$902K Sell
182,231
-22,483
-11% -$94.8K 0.08% 95
2025
Q3 		$923K Buy
204,714
+12,200
+6% +$41.5K 0.08% 95
2025
Q2 		$601K Sell
192,514
-30,000
-13% -$84.5K 0.06% 113
2025
Q1 		$559K Sell
222,514
-92,000
-29% -$288K 0.06% 107
2024
Q4 		$975K Buy
314,514
+7,189
+2% +$18.4K 0.09% 91
2024
Q3 		$731K Buy
307,325
+26,866
+10% +$59.5K 0.07% 110
2024
Q2 		$710K Sell
280,459
-58,305
-17% -$148K 0.07% 99
2024
Q1 		$999K Buy
338,764
+8,641
+3% +$26.5K 0.1% 97
2023
Q4 		$994K Buy
330,123
+245,123
+288% +$789K 0.11% 93
2023
Q3 		$322K Buy
85,000
+65,000
+325% +$238K 0.04% 182
2023
Q2 		$87.4K Buy
+20,000
New +$71.7K 0.01% 247

Other funds holding DRTS

AC
Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
WC
Woodstock Corp Boston, Massachusetts $1.2B AUM 26.37% 1-Year Est. Return
FGG
Financial Guidance Group Palm Harbor, Florida $267M AUM 19.62% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
WC
Waterloo Capital Austin, Texas $1.78B AUM 27.25% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return
OWA
Opal Wealth Advisors Jericho, New York $463M AUM 20.47% 1-Year Est. Return
TVWM
Tower View Wealth Management Shorewood, Wisconsin $227M AUM 41.04% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

Levin Capital Strategies's DRTS Position: Q2 2026 in Review

Levin Capital Strategies increased its Alpha Tau Medical (DRTS) stake by 21% in Q2 2026, buying an estimated $201K and bringing the position to 128,594 shares worth $1.62M. The position accounts for 0.11% of the portfolio, ranked #114.

Levin Capital Strategies first reported a position in DRTS in Q2 2023 and has held it in 13 quarters since. 15 funds tracked by Wall St. Rank hold DRTS as of Q2 2026.

  • Levin Capital Strategies held 128,594 shares of Alpha Tau Medical worth $1.62M as of Q2 2026.
  • Levin Capital Strategies bought 22,171 Alpha Tau Medical shares in Q2 2026, an estimated $201K.
  • Alpha Tau Medical made up 0.11% of Levin Capital Strategies's portfolio in Q2 2026, its #114 holding.
  • Levin Capital Strategies first reported a position in Alpha Tau Medical in Q2 2023 and has held it in 13 quarters since.
  • 15 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q2 2026.

Based on Levin Capital Strategies's 13F filing for Q2 2026, filed 31 Jul 2026.